Ragon Institute study uncovers how certain antibodies help fight tuberculosis

Alter Lab Study reveals properties of antibodies that restrict mycobacterium tuberculosis - paving way for new therapies

2025-05-30

(Press-News.org) Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body’s ability to fight Mycobacterium tuberculosis (Mtb), the bacteria responsible for tuberculosis (TB). Despite decades of research, TB remains one of the deadliest infectious diseases worldwide, with about 10 million new cases and 1.6 million deaths annually. Currently, there is no highly effective vaccine, highlighting the urgent need for new insights and treatments.

In a study published today in Immunity, Ragon faculty member Galit Alter, PhD and previous post-doctoral trainee Patricia Grace, PhD, now at University of Pittsburgh, partnered with Bryan Bryson, PhD, associate member Sarah Fortune, PhD and a team of collaborators, to collect the largest library of monoclonal antibodies to Mycobacterium tuberculosis (Mtb) the bacteria that causes Tuberculosis. The team identified specific antibody features that significantly limit the growth of Mtb. This research reveals critical new insights into how antibodies interact with immune cells in the lungs to restrict Mtb infection, laying the groundwork for potential antibody-based therapies or vaccines against tuberculosis, both of which are urgently needed.

The team investigated monoclonal antibodies (mAbs), highly specialized antibodies engineered to target specific components of Mtb. They screened a broad library of these antibodies, targeting many different components of the bacteria, to determine which could effectively reduce bacterial growth in infected mice. They found that particular antibodies targeting different parts of the bacteria—both surface proteins and internal antigens—could effectively restrict Mtb growth, challenging previous assumptions that only antibodies recognizing surface structures could help fight TB.

To better understand the mechanisms behind this antibody-mediated protection, researchers closely examined one particularly effective antibody targeting a molecule called lipoarabinomannan (LAM), found on the bacterial cell surface. By engineering the antibody constant domain (Fc), to control the killing activities of the antibody, the researchers discovered that maximal bacterial control was achieved when antibodies redirected innate immune cell recruitment and activation. Particularly, antibodies able to redirect the bacteria to neutrophils provided the greatest level of protection.

This discovery highlights a previously unrecognized way antibodies can work against TB not merely by neutralizing pathogens directly, but by reshaping immune cell functions within infected tissues. Given the rise in antibiotic resistant bacteria, understanding these immune mechanisms opens new avenues for novel therapeutic and vaccine design that are urgently needed to combat TB. Moreover, this study unlocks future approaches to rapidly discover and design monoclonal therapeutics to a broader array of antibiotic-resistant bacteria in the future.

END

ELSE PRESS RELEASES FROM THIS DATE:

Mangroves show surprising resilience to storms in a changing climate

2025-05-30

Dense, spindly mangrove forests line the coast of tropical regions, buffering coastal flooding and providing a valuable sink for carbon, but there is concern that more intense and frequent storms due to climate change could have prolonged impacts on these ecosystems. A new study by Yale School of Environment scientists, however, suggests that these systems may be more resilient than expected. The team calculated the “recovery debt” of mangroves in Everglades National Park after hurricanes Wilma and Irma, showing that all the carbon lost during the storms was recovered within four years. (Wilma hit South Florida in 2005 and Irma hit ...

Experiences with discrimination may raise rise of early psychotic episodes: NYU study

2025-05-30

Prevailing theories about why young people experience psychotic breaks at a young age rely on individual factors like exposure to child abuse, school bullying, or drugs. But a new study from the NYU Silver School of Social Work suggests that broader social factors, such as racial inequality and experience with police violence, might contribute to the proportionately higher rates of psychosis seen among low-income young adults of color. The study, “Social Defeat and Psychosis in the United States,” ...

Common gene variant doubles dementia risk for men

2025-05-30

New research has found that men who carry a common genetic variant are twice as likely to develop dementia in their lifetime compared to women. The research, published in Neurology, used data from the ASPirin in Reducing Events in the Elderly (ASPREE) trial to investigate whether people who had variants in the haemochromatosis (HFE) gene, which is critical for regulating iron levels in the body, might be at increased risk of dementia. Co-author Professor John Olynyk, from the Curtin Medical School, said one in three people carry one ...

Nutritional priorities to support GLP-1 therapy for obesity

2025-05-30

Four leading organizations in lifestyle medicine, obesity medicine, and nutrition—the American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society (TOS)—have jointly released a clinical advisory titled “Nutritional Priorities to Support GLP-1 Therapy for Obesity.” Published across four peer-reviewed journals, this consensus-based guidance reflects an interdisciplinary collaboration to help clinicians support patients receiving GLP-1 receptor agonists for obesity care with evidence-based nutritional and behavioral strategies. GLP-1 ...

Detecting invisible wounds: New study could change how wound closure is defined

2025-05-30

In patients with diabetic foot ulcers that looked healed and met the current definition of a closed wound, closed ulcers with functionally defective skin that lost more body water were likely to re-open, according to a new National Institutes of Health (NIH) Diabetic Foot Consortium study, led by researchers at the University of Pittsburgh and published today in Diabetes Care. The U.S. Food and Drug Administration (FDA) currently defines a closed wound as one where the surface is completely covered by new skin and ...

Routine breast cancer screening brings better outcomes for patients

2025-05-30

OAK BROOK, Ill. – Researchers have discovered that, compared to breast cancer that is symptom-detected, patients with breast cancer detected via routine screening mammography are more likely to have improved clinical outcomes, according to a study published today in Radiology: Imaging Cancer, a journal of the Radiological Society of North America (RSNA). While it is commonly understood that early detection of breast cancer results in better patient outcomes, national cancer registries in the U.S. and Canada don’t track the method ...

New ACS study: Number of cancer survivors in the U.S. reaches 18.6 million — projected to exceed 22 million by 2035

2025-05-30

The number of people living with a history of cancer in the United States is estimated at 18.6 million as of January 1, 2025 and projected to exceed 22 million by 2035, according to a new report, Cancer Treatment and Survivorship Statistics, 2025, led by the American Cancer Society (ACS). The study also found notable disparities in treatment for many common cancers, including lung and colorectal. The findings are published today in CA: A Cancer Journal for Clinicians, alongside its consumer-friendly companion, Fast Facts: Cancer Treatment and Survivorship, available on cancer.org. “Behind every survivor of ...

Innovative immunotherapy shows promise against aggressive T cell cancers

2025-05-30

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led by researchers at Washington University School of Medicine in St. Louis. The clinical trial evaluated the safety and efficacy of an innovative CAR-T cell immunotherapy that is specifically designed to attack cancerous T cells. Participants in the trial had been diagnosed with rare cancers — T cell acute lymphoblastic leukemia or T cell lymphoblastic lymphoma — and had run out of treatment options after standard therapy proved ineffective for them. With the new immunotherapy, most of ...

Scientists identify diagnostic aid to determine risk of diabetic foot ulcer recurrence

2025-05-30

A research team funded by the National Institutes of Health (NIH) has identified a diagnostic aid that has the potential to accurately predict the recurrence of diabetic foot ulcers that appear to be fully healed. By measuring the skin’s barrier function through a process known as trans-epidermal water loss, or TEWL, scientists were able to determine which wounds were more likely to reopen. TEWL measurements are a major factor in burn care, where deep layers of the skin are often damaged. The findings suggest that full restoration of skin ...

NYU researchers devise method to identify ‘311’ underreporting of heat and hot water shortages

2025-05-30

Complaint lines such as New York City’s 311 let people report quality-of-life problems in their building or neighborhood, from excessive noise to illegal parking. But resident-generated data typically suffer from reporting bias, with some neighborhoods and addresses calling attention to problems at lower rates than others. A team of New York University researchers has developed an automated modeling tool to help the New York City government estimate 311 under-reporting by building, neighborhood, and subpopulation. In a new study, published today [May 30] in Annals of Applied Statistics, the researchers describe a method that, using machine learning, can estimate the potential ...